Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives
<p>The objective of this communication is to present and analyze the recent results from the LAPIBSS study in order to improve future clinical trials on the effects of Lactobacillus strains in the treatment of irritable bowel syndrome (IBS). Using a tightly-controlled clinical trial protocol w...
Zapisane w:
Główni autorzy: | Jean-Michel Maixent (Autor), Olivier Pons (Autor), Souad R Sennoune (Autor), Stéphane Sadrin (Autor) |
---|---|
Format: | Książka |
Wydane: |
Archives of Clinical Gastroenterology - Peertechz Publications,
2020-05-18.
|
Hasła przedmiotowe: | |
Dostęp online: | Connect to this object online. |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
ANTIBIOTIC SUSCEPTIBILITY OF POTENTIALLY PROBIOTIC LACTOBACILLUS STRAINS
od: Junhua Han, i wsp.
Wydane: (2015) -
Methods of Determining Irritable Bowel Syndrome and Efficiency of Probiotics in Treatment: A Review
od: Geetika M. Ahlawat, Ph. D., i wsp.
Wydane: (2023) -
The role of probiotics in current algorithms for the treatment of irritable bowel syndrome: A review
od: Dmitry N. Andreev, i wsp.
Wydane: (2023) -
Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model
od: Ki-Bae Hong, i wsp.
Wydane: (2019) -
Lactobacillus rhamnosus for treating irritable bowel syndrome in children - a systematic review with meta-analysis
od: Joanna Tarnoruda, i wsp.
Wydane: (2024)